← Back to Screener
ScreenerNewsCompareWatchlist
VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesNewsCompareWatchlist
AnalyzeValuationTotal ReturnDCA CalculatorInsider Activity
  1. Home
  2. PRGO
  3. P/E History
OverviewPriceRevenueEarningsP/ERatiosDividendTargets

PRGO logoPerrigo Company plc (PRGO) P/E Ratio History

Historical price-to-earnings valuation from 1992 to 2023

Current P/E
-1.2
Undervalued
5Y Avg P/E
98.2
-101% vs avg
PE Percentile
0%
Low
PEG Ratio
N/A
N/A
TTM EPS$-10.29
Price$12.26
5Y PE Range30.4 - 439.5
Earnings YieldN/A

Loading P/E history...

PRGO Valuation Context

How does the current P/E compare to historical and market benchmarks?

vs. 5Y Average
-1.2vs98.2
-101%
Cheap vs History
vs. Healthcare
-1.2vs22.2
-105%
Below Sector
vs. S&P 500
-1.2vs25.2
-105%
Below Market
PEG Analysis
N/A
P/E ÷ EPS Growth
Based on -723% EPS growth (1Y)
Export Data

P/E Ratio Analysis

As of May 6, 2026, Perrigo Company plc (PRGO) trades at a price-to-earnings ratio of -1.2x, with a stock price of $12.26 and trailing twelve-month earnings per share of $-10.29.

The current P/E is 101% below its 5-year average of 98.2x. Over the past five years, PRGO's P/E has ranged from a low of 30.4x to a high of 439.5x, placing the current valuation at the 0th percentile of its historical range.

Compared to the Healthcare sector median P/E of 22.2x, PRGO trades at a 105% discount to its sector peers. The sector includes 241 companies with P/E ratios ranging from 0.0x to 178.0x.

Relative to the broader market, PRGO trades at a notable discount to the S&P 500 median P/E of 25.2x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.

For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our PRGO DCF Valuation Calculator →

Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.

PRGO P/E vs Peers

P/E ratio compared to closely matched public peers

CompanyMarket CapP/E RatioPEG RatioEPS Growth (1Y)
HLN logoHLNHaleon plc
$41B18.92.23+13%
PBH logoPBHPrestige Consumer Healthcare Inc.
$3B12.7Lowest1.40+3%
TEVA logoTEVATeva Pharmaceutical Industries Limited
$42B30.3-+183%Best
AMRX logoAMRXAmneal Pharmaceuticals, Inc.
$4B61.9-+158%
HI logoHIHillenbrand, Inc.
$2B52.4-+120%
MCK logoMCKMcKesson Corporation
$91B28.90.74Best+15%
CAH logoCAHCardinal Health, Inc.
$45B29.7-+87%
CVS logoCVSCVS Health Corporation
$110B62.5--62%

Peers sorted by market capitalization. P/E below peers may indicate undervaluation or lower growth expectations. Consider PEG ratio for growth-adjusted comparison.

PRGO Historical P/E Data (1992–2023)

Quarterly P/E ratios calculated from closing price and TTM EPS

QuarterDatePriceTTM EPSP/E Ratiovs Avg
FY2023 Q3Sat Sep 30 2023 00:00:00 GM$31.95$0.07439.5x+869%
FY2020 Q2Sat Jun 27 2020 00:00:00 GM$53.94$1.7431.0x-32%
FY2020 Q1Sat Mar 28 2020 00:00:00 GM$46.10$1.3733.6x-26%
FY2019 Q4$51.66$1.0748.3x+6%
FY2019 Q3Sat Sep 28 2019 00:00:00 GM$54.98$1.8130.4x-33%
FY2019 Q2Sat Jun 29 2019 00:00:00 GM$47.62$0.6573.3x+61%
FY2019 Q1Sat Mar 30 2019 00:00:00 GM$48.16$0.8457.3x+26%
FY2018 Q4Mon Dec 31 2018 00:00:00 GM$38.75$0.9441.2x-9%
FY2018 Q3Sat Sep 29 2018 00:00:00 GM$70.80$0.8682.3x+81%
FY2018 Q2Sat Jun 30 2018 00:00:00 GM$72.91$1.6643.9x-3%
FY2018 Q1Sat Mar 31 2018 00:00:00 GM$83.34$0.9191.6x+102%
FY2017 Q4Sun Dec 31 2017 00:00:00 GM$87.16$0.84103.8x+129%

Average P/E for displayed period: 45.4x

See PRGO's True Return

Price is only half the story. See total return with reinvested dividends.

Launch Calculator

Is PRGO Undervalued?

DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.

View Valuation

Compare PRGO vs DBVT

Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..

Start Comparison

PRGO — Frequently Asked Questions

Quick answers to the most common questions about buying PRGO stock.

Is PRGO stock overvalued or undervalued?

PRGO trades at -1.2x P/E, below its 5-year average of 98.2x. At the N/A percentile of historical range, the stock is priced at a discount to its own history.

How does PRGO's valuation compare to peers?

Perrigo Company plc P/E of -1.2x compares to sector median of 22.2x. The discount suggests lower growth expectations or higher risk.

What is PRGO's PEG ratio?

PRGO PEG ratio is N/A. Above 2.0 indicates premium valuation relative to growth rate. Historical P/E data spans 1992-2023.

VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Patterns find ideas. Fundamentals build conviction.

Data updated daily

Quick Links

  • Home
  • Screener
  • Themes
  • Market Valuation
  • Valuation
  • Compare
  • Total Return
  • DCA Calculator
  • News
  • Insights
  • Methodology
  • How It Works
  • Profile

Popular Screens

  • VCP Hot
  • VCP Warm
  • Value Screens
  • Growth Screens
  • Momentum Screens
  • Technical Screens
  • Quality Screens

Community

  • Follow @VCPScanner on X

Get weekly stock ideas — free

© 2026 VCP Scanner. All rights reserved.
About·Privacy Policy·Terms of Service
Not financial advice. Do your own research.

PRGO P/E Ratio History (1992–2023)

P/E ratio calculated as closing price divided by trailing 12-month diluted EPS at each quarter end.